![Biotech companies like University of Melbourne success story Fibrotech Therapeutics lead the way.](/web/20161119001925im_/http://www.smh.com.au/content/dam/images/g/j/6/8/u/5/image.related.landscape.460x307.gqer1q.png/1469590289682.png)
Off to a good university start-up
We need a common yardstick measuring new venture creation in the tertiary sector.
Tony Featherstone writes on Personal Finance specialising in Superannuation & SMSFs, Specialist Investments.
We need a common yardstick measuring new venture creation in the tertiary sector.
Poor record-keeping and information management still a problem for business.
Save articles for later.
Subscribe for unlimited access to news. Login to save articles.
Return to the homepage by clicking on the site logo.